TRICUSPID REGURGITATION
Clinical trials for TRICUSPID REGURGITATION explained in plain language.
Never miss a new study
Get alerted when new TRICUSPID REGURGITATION trials appear
Sign up with your email to follow new studies for TRICUSPID REGURGITATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New device aims to fix leaky heart valves without open surgery
Disease control OngoingThis study is testing a device called the Cardioband FIT System to repair leaky tricuspid heart valves. Doctors will use a catheter (a thin tube) to place the device in the heart without major open-heart surgery. The goal is to see if this approach is safe and can help reduce the…
Matched conditions: TRICUSPID REGURGITATION
Phase: NA • Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Apr 02, 2026 04:11 UTC
-
New drug trial aims to break vicious cycle in heart failure
Disease control OngoingThis study is testing whether a drug called enavogliflozin can help people who have heart failure along with a leaky tricuspid heart valve. About 541 participants will take the drug or a placebo for 18 months to see if it reduces serious heart-related events, hospital visits, or …
Matched conditions: TRICUSPID REGURGITATION
Phase: PHASE3 • Sponsor: Asan Medical Center • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Heart valve procedure danger zone: study probes sudden blood pressure crashes
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at a serious complication called acute hemodynamic instability (AHI), which is a dangerous drop in blood pressure, after a minimally invasive heart valve replacement. Researchers will review medical records of 140 high-risk heart failure patients who were too sic…
Matched conditions: TRICUSPID REGURGITATION
Sponsor: Columbia University • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:39 UTC